Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis Vaccines”

117 trials

Showing 20 of 117 results

Not applicableLooking for participantsNCT05571735
What this trial is testing

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Who this might be right for
Covid-19 PandemicsTuberculosis
University of Oxford 133
Early research (Phase 1)Study completedNCT01829490
What this trial is testing

Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults

Who this might be right for
Tuberculosis
University of Oxford 42
Early research (Phase 1)Study completedNCT00922363
What this trial is testing

Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers

Who this might be right for
Tuberculosis
Statens Serum Institut 38
Testing effectiveness (Phase 2)Ended earlyNCT01424501
What this trial is testing

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease

Who this might be right for
Tuberculosis
GlaxoSmithKline 142
Early research (Phase 1)Study completedNCT03026972
What this trial is testing

A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried

Who this might be right for
Tuberculosis
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 25
Early research (Phase 1)WithdrawnNCT03159975
What this trial is testing

Safety and Immunogenicity Study of GX-70 in TB Patient

Who this might be right for
Pulmonary TuberculosesHigh Risk Factors for RelapseTreatment Failure
Yonsei University
Testing effectiveness (Phase 2)WithdrawnNCT05539989
What this trial is testing

Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa

Who this might be right for
TuberculosisHIV Infections
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Large-scale testing (Phase 3)Ended earlyNCT04453293
What this trial is testing

Immunization With BCG Vaccine to Prevent Tuberculosis Infection

Who this might be right for
Tuberculosis Infection
Henry M. Jackson Foundation for the Advancement of Military Medicine 16
Testing effectiveness (Phase 2)Study completedNCT00397943
What this trial is testing

Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults

Who this might be right for
Tuberculosis
GlaxoSmithKline 110
Testing effectiveness (Phase 2)Study completedNCT02712424
What this trial is testing

DAR-901 TB Booster Vaccine to Prevent TB in Adolescents

Who this might be right for
Tuberculosis
Dartmouth-Hitchcock Medical Center 625
Post-approval studies (Phase 4)Study completedNCT01811823
What this trial is testing

Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults

Who this might be right for
InfluenzaHIVTuberculosis
University of Witwatersrand, South Africa 301
Early research (Phase 1)Study completedNCT00546273
What this trial is testing

Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers

Who this might be right for
Latent Tuberculosis InfectionTuberculosis
Germans Trias i Pujol Hospital 24
Early research (Phase 1)Study completedNCT01378312
What this trial is testing

Evaluate Safety and Immunogenicity of AERAS-402

Who this might be right for
Tuberculosis
Aeras 12
Early research (Phase 1)Study completedNCT00548444
What this trial is testing

T-Cell Turnover Following Vaccination With MVA85A

Who this might be right for
Tuberculosis
University of Oxford 12
Early research (Phase 1)UnknownNCT03806699
What this trial is testing

Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Adolescent

Who this might be right for
Tuberculosis
Quratis Inc. 36
Early research (Phase 1)Study completedNCT05592223
What this trial is testing

Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

Who this might be right for
Tuberculosis
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT03722472
What this trial is testing

Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults

Who this might be right for
Pulmonary TB
Access to Advanced Health Institute (AAHI) 48
Early research (Phase 1)Study completedNCT00291889
What this trial is testing

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

Who this might be right for
Tuberculosis (TB)
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06997367
What this trial is testing

Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)

Who this might be right for
Tuberculosis (TB)
Bharat Biotech International Limited 164
Early research (Phase 1)Study completedNCT05537038
What this trial is testing

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers

Who this might be right for
Tuberculosis
BioNTech SE 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation